{"id":147319,"date":"2021-04-08T00:53:10","date_gmt":"2021-04-08T00:53:10","guid":{"rendered":"https:\/\/labinsights.com\/acf_article\/cac-hoi-dong-chuyen-ve-khoi-u-cap-do-phan-tu-o-chau-a-bien-du-lieu-ngs-next-generation-sequencing-cong-nghe-giai-trinh-tu-the-he-moi-thanh-cac-ke-hoach-dieu-tri-ung-thu-kha-thi\/"},"modified":"2026-02-26T09:23:08","modified_gmt":"2026-02-26T09:23:08","slug":"molecular-tumour-boards-in-asia-turning-ngs-data-into-actionable-cancer-plans","status":"publish","type":"acf_article","link":"https:\/\/labinsights.com\/vi\/operations\/clinical-decision-support\/molecular-tumour-boards-in-asia-turning-ngs-data-into-actionable-cancer-plans\/","title":{"rendered":"Ca\u0301c h\u1ed9i \u0111\u1ed3ng chuy\u00ean v\u00ea\u0300 kh\u1ed1i u c\u00e2\u0301p \u0111\u00f4\u0323 ph\u00e2n t\u1eed \u1edf Ch\u00e2u \u00c1: bi\u1ebfn d\u1eef li\u1ec7u NGS (next-generation sequencing, c\u00f4ng ngh\u1ec7 gi\u1ea3i tr\u00ecnh t\u1ef1 th\u1ebf h\u1ec7 m\u1edbi) th\u00e0nh c\u00e1c k\u1ebf ho\u1ea1ch \u0111i\u1ec1u tr\u1ecb ung th\u01b0 kh\u1ea3 thi"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

B\u00e0i vi\u1ebft n\u00e0y l\u00e0 m\u1ed9t ph\u1ea7n c\u1ee7a lo\u1ea1t nghi\u00ean c\u1ee9u \u0111i\u1ec3n h\u00ecnh v\u1ec1 vi\u1ec7c s\u1eed d\u1ee5ng NGS (next-generation sequencing, c\u00f4ng ngh\u1ec7 gi\u1ea3i tr\u00ecnh t\u1ef1 th\u1ebf h\u1ec7 m\u1edbi) v\u00e0 c\u00e1c c\u00f4ng c\u1ee5 k\u1ef9 thu\u1eadt s\u1ed1 \u0111\u1ec3 th\u00fac \u0111\u1ea9y ung th\u01b0 h\u1ecdc ch\u00ednh x\u00e1c t\u1ea1i khu v\u1ef1c Ch\u00e2u \u00c1 – Th\u00e1i B\u00ecnh D\u01b0\u01a1ng. Vui l\u00f2ng cu\u1ed9n xu\u1ed1ng cu\u1ed1i b\u00e0i vi\u1ebft \u0111\u1ec3 xem danh s\u00e1ch \u0111\u1ea7y \u0111\u1ee7.<\/em><\/p>

Tr\u00ean kh\u1eafp khu v\u1ef1c Ch\u00e2u \u00c1 – Th\u00e1i B\u00ecnh D\u01b0\u01a1ng, vi\u1ec7c s\u1eed d\u1ee5ng ng\u00e0y c\u00e0ng nhi\u1ec1u c\u00f4ng ngh\u1ec7 gi\u1ea3i tr\u00ecnh t\u1ef1 th\u1ebf h\u1ec7 m\u1edbi (NGS) trong c\u00e1c ph\u00f2ng x\u00e9t nghi\u1ec7m l\u00e2m s\u00e0ng \u0111ang th\u00fac \u0111\u1ea9y nh\u1eefng c\u1ea3i ti\u1ebfn \u0111\u00e1ng k\u1ec3 trong x\u00e9t nghi\u1ec7m ung th\u01b0. C\u00e1c nh\u00e0 nghi\u00ean c\u1ee9u b\u1ec7nh h\u1ecdc \u0111ang gi\u1ea3i tr\u00ecnh t\u1ef1 kh\u1ed1i u \u0111\u1ec3 gi\u00fap ch\u1ea9n \u0111o\u00e1n ung th\u01b0 ch\u00ednh x\u00e1c h\u01a1n, x\u00e1c \u0111\u1ecbnh c\u00e1c d\u1ea5u hi\u1ec7u ti\u00ean l\u01b0\u1ee3ng quan tr\u1ecdng, h\u01b0\u1edbng d\u1eabn l\u1ef1a ch\u1ecdn ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb b\u1eb1ng c\u00e1ch ph\u00e1t hi\u1ec7n c\u00e1c \u0111\u1ed9t bi\u1ebfn li\u00ean quan \u0111\u1ebfn li\u1ec7u ph\u00e1p nh\u1eafm m\u1ee5c ti\u00eau, v\u00e0 th\u1eadm ch\u00ed k\u1ebft n\u1ed1i b\u1ec7nh nh\u00e2n v\u1edbi c\u00e1c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng. D\u1eef li\u1ec7u gi\u1ea3i tr\u00ecnh t\u1ef1 gen c\u0169ng \u0111ang \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng \u0111\u1ec3 theo d\u00f5i b\u1ec7nh nh\u00e2n trong giai \u0111o\u1ea1n thuy\u00ean gi\u1ea3m, cung c\u1ea5p c\u00e1c d\u1ea5u hi\u1ec7u c\u1ea3nh b\u00e1o s\u1edbm trong tr\u01b0\u1eddng h\u1ee3p ung th\u01b0 t\u00e1i ph\u00e1t.<\/p>

V\u00ec t\u1ea5t c\u1ea3 nh\u1eefng l\u00fd do n\u00e0y, c\u00e1c nh\u00e0 nghi\u00ean c\u1ee9u b\u1ec7nh h\u1ecdc \u0111ang \u0111\u00f3ng vai tr\u00f2 ng\u00e0y c\u00e0ng quan tr\u1ecdng trong vi\u1ec7c ch\u0103m s\u00f3c b\u1ec7nh nh\u00e2n ung th\u01b0. \u0110i\u1ec1u n\u00e0y th\u1ec3 hi\u1ec7n r\u00f5 nh\u1ea5t qua s\u1ef1 xu\u1ea5t hi\u1ec7n c\u1ee7a c\u00e1c H\u1ed9i \u0111\u1ed3ng chuy\u00ean v\u00ea\u0300 kh\u1ed1i u c\u00e2\u0301p \u0111\u00f4\u0323 ph\u00e2n t\u1eed (MTBs), t\u1ea1i m\u1ed9t s\u1ed1 c\u01a1 s\u1edf b\u1ec7nh vi\u1ec7n, ch\u00fang \u0111ang b\u1ed5 sung ho\u1eb7c th\u1eadm ch\u00ed thay th\u1ebf c\u00e1c cu\u1ed9c h\u1ecdp h\u1ed9i \u0111\u1ed3ng chuy\u00ean khoa kh\u1ed1i u truy\u1ec1n th\u1ed1ng.\u0110\u0103ng k\u00fd \u0111\u1ec3 nh\u1eadn tin t\u1ee9c v\u00e0 c\u1eadp nh\u1eadt m\u1edbi nh\u1ea5t c\u1ee7a LabInsights<\/p>

MTBs (Molecular tumour boards, ca\u0301c H\u1ed9i \u0111\u1ed3ng chuy\u00ean v\u00ea\u0300 kh\u1ed1i u c\u00e2\u0301p \u0111\u00f4\u0323 ph\u00e2n t\u1eed) l\u00e0 g\u00ec?<\/span><\/p><\/div>

Gi\u1ed1ng nh\u01b0 c\u00e1c cu\u1ed9c h\u1ecdp h\u1ed9i \u0111\u1ed3ng b\u00e1c s\u0129 ti\u00eau chu\u1ea9n, MTBs (Molecular tumour boards, ca\u0301c H\u1ed9i \u0111\u1ed3ng chuy\u00ean v\u00ea\u0300 kh\u1ed1i u c\u00e2\u0301p \u0111\u00f4\u0323 ph\u00e2n t\u01b0\u0309) la\u0300 nh\u01b0\u0303ng t\u00f4\u0309 ch\u01b0\u0301c t\u00e2\u0323p h\u01a1\u0323p c\u00e1c chuy\u00ean gia chuy\u00ean \u0111i\u00ea\u0300u tri\u0323 c\u00e1c tr\u01b0\u1eddng h\u1ee3p b\u1ec7nh nh\u00e2n c\u1ee5 th\u1ec3. Ph\u1ea7n “ph\u00e2n t\u1eed” c\u1ee7a MTB (Molecular tumour board, H\u1ed9i \u0111\u1ed3ng chuy\u00ean v\u00ea\u0300 kh\u1ed1i u c\u00e2\u0301p \u0111\u00f4\u0323 ph\u00e2n t\u1eed) cho th\u1ea5y c\u00e1c cu\u1ed9c h\u1ecdp n\u00e0y \u0111\u1eb7c bi\u1ec7t ch\u00fa tr\u1ecdng \u0111\u1ebfn c\u00e1c ph\u00e1t hi\u1ec7n ph\u00e2n t\u1eed \u2014 bao g\u1ed3m d\u1eef li\u1ec7u NGS (next-generation sequencing, c\u00f4ng ngh\u1ec7 gi\u1ea3i tr\u00ecnh t\u1ef1 th\u1ebf h\u1ec7 m\u1edbi) v\u00e0 k\u1ebft qu\u1ea3 t\u1eeb c\u00e1c x\u00e9t nghi\u1ec7m ph\u00e2n t\u1eed li\u00ean quan kh\u00e1c \u2014 v\u00e0 c\u00e1ch th\u00f4ng tin \u0111\u00f3 c\u00f3 th\u1ec3 \u0111\u1ecbnh h\u01b0\u1edbng k\u1ebf ho\u1ea1ch \u0111i\u1ec1u tr\u1ecb.<\/p>

MTBs (Molecular tumour boards, ca\u0301c H\u1ed9i \u0111\u1ed3ng chuy\u00ean v\u00ea\u0300 kh\u1ed1i u c\u00e2\u0301p \u0111\u00f4\u0323 ph\u00e2n t\u1eed) c\u00f3 th\u1ec3 t\u1eadp h\u1ee3p c\u00e1c b\u00e1c s\u0129 ung th\u01b0, b\u00e1c s\u0129 ph\u1eabu thu\u1eadt, nh\u00e0 khoa h\u1ecdc gen, nh\u00e0 b\u1ec7nh h\u1ecdc ph\u00e2n t\u1eed, chuy\u00ean gia d\u01b0\u1ee3c l\u00fd, chuy\u00ean gia t\u01b0 v\u1ea5n di truy\u1ec1n v\u00e0 c\u00e1c chuy\u00ean gia kh\u00e1c. Nh\u01b0\u0303ng \u0111\u00f4\u0323i ngu\u0303 chuy\u00ean gia n\u00e0y th\u01b0\u1eddng xem x\u00e9t t\u1ea5t c\u1ea3 d\u1eef li\u1ec7u l\u00e2m s\u00e0ng c\u1ee7a b\u1ec7nh nh\u00e2n c\u00f9ng v\u1edbi h\u1ed3 s\u01a1 ph\u00e2n t\u1eed v\u1ec1 b\u1ec7nh ung th\u01b0 c\u1ee7a h\u1ecd, trong m\u1ed9t s\u1ed1 tr\u01b0\u1eddng h\u1ee3p, so s\u00e1nh c\u00e1c \u0111\u1ed9t bi\u1ebfn soma \u0111\u01b0\u1ee3c t\u00ecm th\u1ea5y trong kh\u1ed1i u v\u1edbi c\u00e1c \u0111\u1ed9t bi\u1ebfn d\u00f2ng m\u1ea7m \u0111\u01b0\u1ee3c ph\u00e1t hi\u1ec7n b\u1eb1ng c\u00e1ch gi\u1ea3i tr\u00ecnh t\u1ef1 b\u1ed9 gen c\u1ee7a ch\u00ednh b\u1ec7nh nh\u00e2n.<\/p>

MTBs (Molecular tumour boards, ca\u0301c H\u1ed9i \u0111\u1ed3ng chuy\u00ean v\u00ea\u0300 kh\u1ed1i u c\u00e2\u0301p \u0111\u00f4\u0323 ph\u00e2n t\u1eed) \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng tr\u00ean kh\u1eafp khu v\u1ef1c Ch\u00e2u \u00c1-Th\u00e1i B\u00ecnh D\u01b0\u01a1ng nh\u01b0 th\u1ebf n\u00e0o?<\/h3>

MTBs (Molecular tumour boards, ca\u0301c H\u1ed9i \u0111\u1ed3ng chuy\u00ean v\u00ea\u0300 kh\u1ed1i u c\u00e2\u0301p \u0111\u00f4\u0323 ph\u00e2n t\u1eed) l\u00e0 m\u1ed9t h\u01b0\u01a1\u0301ng t\u01b0\u01a1ng \u0111\u1ed1i m\u1edbi trong vi\u00ea\u0323c ch\u0103m s\u00f3c ung th\u01b0. H\u00f4\u0323i \u0111\u00f4\u0300ng bao h\u00e0m c\u00e1c nguy\u00ean t\u1eafc t\u01b0\u01a1ng t\u1ef1 nh\u01b0 c\u00e1c th\u1ea3o lu\u1eadn v\u1ec1 ch\u0103m s\u00f3c l\u00e2m s\u00e0ng tr\u01b0\u1edbc \u0111\u00e2y, c\u00f9ng v\u1edbi vi\u1ec7c b\u1ed5 sung d\u1eef li\u1ec7u ph\u00e2n t\u1eed ti\u00ean ti\u1ebfn hi\u1ec7n c\u00f3. Do m\u1ee5c \u0111\u00edch c\u1ee7a b\u00e0i vi\u1ebft, ch\u00fang t\u00f4i s\u1ebd t\u1eadp trung v\u00e0o m\u1ed9t s\u1ed1 v\u00ed d\u1ee5 v\u1ec1 c\u00e1ch MTBs (Molecular tumour boards, ca\u0301c H\u1ed9i \u0111\u1ed3ng chuy\u00ean v\u00ea\u0300 kh\u1ed1i u c\u00e2\u0301p \u0111\u00f4\u0323 ph\u00e2n t\u1eed) \u0111\u00e3 \u0111\u01b0\u1ee3c tri\u1ec3n khai trong c\u00e1c ph\u00f2ng xe\u0301t nghi\u1ec7m \u1edf khu v\u1ef1c APAC (Asia-Pacific, Ch\u00e2u \u00c1 – Th\u00e1i B\u00ecnh D\u01b0\u01a1ng).\u00dac<\/p>

Gi\u00e1o s\u01b0 Svetlana Cherepanoff, b\u00e1c s\u0129 m\u00f4 b\u1ec7nh h\u1ecdc m\u1eaft t\u1ea1i B\u1ec7nh vi\u1ec7n St Vincent v\u00e0 SydPath \u1edf New South Wales, l\u00e0 th\u00e0nh vi\u00ean c\u1ee7a nh\u00f3m \u0111i\u1ec1u h\u00e0nh MTB (Molecular tumour board, H\u1ed9i \u0111\u1ed3ng chuy\u00ean v\u00ea\u0300 kh\u1ed1i u c\u00e2\u0301p \u0111\u00f4\u0323 ph\u00e2n t\u1eed) duy nh\u1ea5t v\u1ec1 ung th\u01b0 m\u1eaft t\u1ea1i \u00dac. B\u00e0 c\u00f3 kinh nghi\u1ec7m tr\u1ef1c ti\u1ebfp v\u1ec1 l\u1ee3i \u00edch c\u1ee7a vi\u1ec7c l\u1eadp h\u1ed3 s\u01a1 ph\u00e2n t\u1eed v\u00e0 MTBs (Molecular tumour boards, ca\u0301c H\u1ed9i \u0111\u1ed3ng chuy\u00ean v\u00ea\u0300 kh\u1ed1i u c\u00e2\u0301p \u0111\u00f4\u0323 ph\u00e2n t\u1eed) \u0111a ng\u00e0nh t\u1ea1i \u0111\u00e2y. V\u00ed d\u1ee5, m\u1ed9t MTB (Molecular tumour board, H\u1ed9i \u0111\u1ed3ng chuy\u00ean v\u00ea\u0300 kh\u1ed1i u c\u00e2\u0301p \u0111\u00f4\u0323 ph\u00e2n t\u1eed) cho b\u1ec7nh u h\u1eafc t\u1ed1 m\u00e0ng m\u1ea1ch \u0111\u00e3 t\u00edch h\u1ee3p th\u00e0nh c\u00f4ng th\u00f4ng tin t\u1eeb nhi\u1ec1u ngu\u1ed3n d\u1eef li\u1ec7u, t\u1ea1o \u0111\u1ed9ng l\u1ef1c cho SydPath n\u1ed9p \u0111\u01a1n xin t\u00e0i tr\u1ee3 \u0111\u1ec3 bi\u1ebfn m\u00f4 h\u00ecnh MTB (Molecular tumour board, H\u1ed9i \u0111\u1ed3ng chuy\u00ean v\u00ea\u0300 kh\u1ed1i u c\u00e2\u0301p \u0111\u00f4\u0323 ph\u00e2n t\u1eed) n\u00e0y th\u00e0nh m\u00f4 h\u00ecnh t\u1ef1 duy tr\u00ec<\/a>. Gi\u00e1o s\u01b0 Cherepanoff l\u01b0u \u00fd r\u1eb1ng c\u00e1c c\u00f4ng c\u1ee5 k\u1ef9 thu\u1eadt s\u1ed1 \u0111\u00e3 \u0111\u1ea9y nhanh nhi\u1ec1u quy tr\u00ecnh trong ca\u0301c MTBs (Molecular tumour boards, ca\u0301c H\u1ed9i \u0111\u1ed3ng chuy\u00ean v\u00ea\u0300 kh\u1ed1i u c\u00e2\u0301p \u0111\u00f4\u0323 ph\u00e2n t\u1eed) c\u1ee7a b\u00e0,t\u0103ng t\u1ea7n su\u1ea5t t\u1eeb ch\u1ec9 s\u00e1u l\u1ea7n m\u1ed7i n\u0103m l\u00ean t\u00e1m l\u1ea7n trong b\u1ed1n th\u00e1ng.\u1ea4n \u0110\u1ed9<\/p>

T\u1ea1i B\u1ec7nh vi\u1ec7n Manipal \u1edf Bengaluru, Ba\u0301c s\u0129 Amit Rauthan l\u01b0u \u00fd r\u1eb1ng MTBs (Molecular tumour boards, ca\u0301c H\u1ed9i \u0111\u1ed3ng chuy\u00ean v\u00ea\u0300 kh\u1ed1i u c\u00e2\u0301p \u0111\u00f4\u0323 ph\u00e2n t\u1eed) r\u1ea5t quan tr\u1ecdng \u0111\u1ed1i v\u1edbi vi\u1ec7c ch\u0103m s\u00f3c b\u1ec7nh nh\u00e2n<\/a>, nh\u01b0ng th\u00e0nh c\u00f4ng c\u1ee7a ch\u00fang ph\u1ee5 thu\u1ed9c v\u00e0o kh\u1ea3 n\u0103ng t\u1ed5ng h\u1ee3p v\u00e0 chia s\u1ebb d\u1eef li\u1ec7u c\u1ee7a t\u1ea5t c\u1ea3 c\u00e1c b\u00e1c s\u0129 l\u00e2m s\u00e0ng \u2014 m\u1ed9t \u0111i\u1ec1u \u0111\u01b0\u1ee3c h\u1ed7 tr\u1ee3 r\u1ea5t nhi\u1ec1u b\u1edfi c\u00e1c c\u00f4ng c\u1ee5 k\u1ef9 thu\u1eadt s\u1ed1. “MTBs (Molecular tumour boards, ca\u0301c H\u1ed9i \u0111\u1ed3ng chuy\u00ean v\u00ea\u0300 kh\u1ed1i u c\u00e2\u0301p \u0111\u00f4\u0323 ph\u00e2n t\u1eed) r\u1ea5t h\u1eefu \u00edch v\u00e0 c\u00f3 th\u1ec3 khai th\u00e1c ki\u1ebfn th\u1ee9c c\u1ea7n thi\u1ebft \u0111\u1ec3 hi\u1ec3u c\u00e1c b\u00e1o c\u00e1o NGS (next-generation sequencing, c\u00f4ng ngh\u1ec7 gi\u1ea3i tr\u00ecnh t\u1ef1 th\u1ebf h\u1ec7 m\u1edbi), cho ph\u00e9p \u0111\u1eb7t c\u00e2u h\u1ecfi v\u00e0 gi\u00fap th\u00f4ng tin d\u1ec5 ti\u1ebfp c\u1eadn”, \u00f4ng n\u00f3i, \u0111\u1ed3ng th\u1eddi cho bi\u1ebft th\u00eam r\u1eb1ng ngay c\u1ea3 m\u1ed9t bu\u1ed5i h\u1ecdp 10 ph\u00fat c\u0169ng c\u00f3 th\u1ec3 t\u1ea1o ra s\u1ef1 kh\u00e1c bi\u1ec7t. “Kh\u00f4ng c\u1ea7n ph\u1ea3i l\u00e0 tha\u0300nh l\u00e2\u0323p m\u1ed9t MTB (Molecular tumour board, H\u1ed9i \u0111\u1ed3ng chuy\u00ean v\u00ea\u0300 kh\u1ed1i u c\u00e2\u0301p \u0111\u00f4\u0323 ph\u00e2n t\u1eed) cu\u0323 th\u00ea\u0309 v\u00e0 c\u00f3 th\u1ec3 r\u1ea5t nhanh cho m\u1ed7i b\u00e1o c\u00e1o.”Singapore<\/p>

T\u1ea1i Vi\u1ec7n Ung th\u01b0 \u0110\u1ea1i h\u1ecdc Qu\u1ed1c gia Singapore (NCIS), MTBs (Molecular tumour boards, ca\u0301c H\u1ed9i \u0111\u1ed3ng chuy\u00ean v\u00ea\u0300 kh\u1ed1i u c\u00e2\u0301p \u0111\u00f4\u0323 ph\u00e2n t\u1eed) h\u00e0ng tu\u1ea7n cho ph\u00e9p c\u00e1c chuy\u00ean gia xem x\u00e9t d\u1eef li\u1ec7u ph\u00e2n t\u00edch c\u1ea5u tr\u00fac ph\u00e2n t\u01b0\u0309<\/a> m\u1ed9t c\u00e1ch th\u01b0\u1eddng xuy\u00ean. Nh\u00f3m nghi\u00ean c\u1ee9u bao g\u1ed3m c\u00e1c chuy\u00ean gia ph\u00e1t tri\u1ec3n thu\u1ed1c giai \u0111o\u1ea1n \u0111\u1ea7u v\u00e0 chuy\u00ean bi\u1ec7t v\u1ec1 v\u1ecb tr\u00ed kh\u1ed1i u, t\u1eadp trung v\u00e0o c\u1ea5u tr\u00fac \u0111\u1ed9t bi\u1ebfn ri\u00eang bi\u1ec7t c\u1ee7a t\u1eebng b\u1ec7nh nh\u00e2n \u0111\u1ec3 x\u00e2y d\u1ef1ng k\u1ebf ho\u1ea1ch \u0111i\u1ec1u tr\u1ecb. “M\u1ed7i lo\u1ea1i ung th\u01b0 \u0111\u1ec1u l\u00e0 b\u1ec7nh hi\u1ebfm g\u1eb7p do s\u1ef1 \u0111a d\u1ea1ng c\u1ee7a c\u00e1c c\u1ea5u tr\u00fac \u0111\u1ed9t bi\u1ebfn t\u1ed3n t\u1ea1i trong kh\u1ed1i u c\u1ee7a m\u1ed7i b\u1ec7nh nh\u00e2n”, Ba\u0301c s\u0129 David Tan, b\u00e1c s\u0129 ung th\u01b0 t\u1ea1i NCIS (National University Cancer Institute, Singapore, Vi\u1ec7n Ung th\u01b0 \u0110\u1ea1i h\u1ecdc Qu\u1ed1c gia Singapore), cho bi\u1ebft. “D\u1eef li\u1ec7u \u0111\u1ed9t bi\u1ebfn n\u00e0y c\u0169ng t\u1ea1o \u0111i\u1ec1u ki\u1ec7n thu\u1eadn l\u1ee3i cho vi\u1ec7c ph\u00e1t tri\u1ec3n thu\u1ed1c d\u1ef1a tr\u00ean d\u1ea5u \u1ea5n sinh h\u1ecdc theo c\u00e1ch kh\u00f4ng ph\u00e2n bi\u1ec7t s\u1eafc t\u1ed9c, \u0111i\u1ec1u n\u00e0y \u0111\u1eb7c bi\u1ec7t quan tr\u1ecdng \u1edf ch\u00e2u \u00c1.”H\u00e0n Qu\u1ed1c<\/p>

Gi\u00e1o s\u01b0 Jee Hyun Kim, chuy\u00ean gia ung th\u01b0 v\u00fa t\u1ea1i B\u1ec7nh vi\u1ec7n Bundang, \u0110\u1ea1i h\u1ecdc Qu\u1ed1c gia Seoul, tham gia c\u00e1c nghi\u00ean c\u1ee9u MTBs (Molecular tumour boards, ca\u0301c H\u1ed9i \u0111\u1ed3ng chuy\u00ean v\u00ea\u0300 kh\u1ed1i u c\u00e2\u0301p \u0111\u00f4\u0323 ph\u00e2n t\u1eed) \u0111\u1ec3 gi\u00fap gi\u1ea3i th\u00edch k\u1ebft qu\u1ea3 <\/a> NGS (next-generation sequencing, c\u00f4ng ngh\u1ec7 gi\u1ea3i tr\u00ecnh t\u1ef1 th\u1ebf h\u1ec7 m\u1edbi) v\u00e0 t\u1ea7m quan tr\u1ecdng c\u1ee7a vi\u1ec7c \u00e1p d\u1ee5ng d\u1eef li\u1ec7u n\u00e0y v\u00e0o nhi\u1ec1u ca ung th\u01b0 h\u01a1n. Gi\u00e1o s\u01b0 Kim \u0111\u00e3 ch\u1ee9ng ki\u1ebfn nh\u1eefng k\u1ebft qu\u1ea3 r\u1ea5t t\u00edch c\u1ef1c \u1edf ch\u00ednh b\u1ec7nh nh\u00e2n c\u1ee7a m\u00ecnh, \u0111i\u1ec1u n\u00e0y \u0111\u00e3 l\u00e0m t\u0103ng \u0111\u00e1ng k\u1ec3 vi\u1ec7c s\u1eed d\u1ee5ng d\u1eef li\u1ec7u NGS (next-generation sequencing, c\u00f4ng ngh\u1ec7 gi\u1ea3i tr\u00ecnh t\u1ef1 th\u1ebf h\u1ec7 m\u1edbi) c\u1ee7a b\u00e0. B\u00e0 hy v\u1ecdng r\u1eb1ng c\u00e1c b\u1eb1ng ch\u1ee9ng m\u1ea1nh m\u1ebd s\u1ebd \u0111\u01b0\u1ee3c \u0111\u01b0a v\u00e0o c\u00e1c khuy\u1ebfn ngh\u1ecb v\u00e0 \u0111\u00e1nh gi\u00e1 h\u01b0\u1edbng d\u1eabn \u0111\u1ec3 ch\u1ee9ng minh c\u00e1ch c\u00e1c li\u1ec7u ph\u00e1p \u0111\u01b0\u1ee3c h\u01b0\u1edbng d\u1eabn b\u1edfi NGS (next-generation sequencing, c\u00f4ng ngh\u1ec7 gi\u1ea3i tr\u00ecnh t\u1ef1 th\u1ebf h\u1ec7 m\u1edbi) c\u1ea3i thi\u1ec7n kh\u1ea3 n\u0103ng s\u1ed1ng s\u00f3t.\u0110\u00e0i Loan<\/p>

T\u1ea1i B\u1ec7nh vi\u1ec7n \u0110\u1ea1i h\u1ecdc Y khoa Trung Qu\u1ed1c, Ba\u0301c s\u0129 Jan-Gowth Chang cho bi\u1ebft MTBs (Molecular tumour boards, ca\u0301c H\u1ed9i \u0111\u1ed3ng chuy\u00ean v\u00ea\u0300 kh\u1ed1i u c\u00e2\u0301p \u0111\u00f4\u0323 ph\u00e2n t\u1eed) \u0111\u01b0\u1ee3c t\u1ed5 ch\u1ee9c m\u1ed9t ho\u1eb7c hai l\u1ea7n m\u1ed9t th\u00e1ng <\/a> \u0111\u1ec3 t\u1eadp trung v\u00e0o nh\u1eefng b\u1ec7nh nh\u00e2n c\u00f3 k\u1ebft qu\u1ea3 NGS (next-generation sequencing, c\u00f4ng ngh\u1ec7 gi\u1ea3i tr\u00ecnh t\u1ef1 th\u1ebf h\u1ec7 m\u1edbi) k\u00e9m, c\u1ea7n \u0111\u01b0\u1ee3c c\u00e1c nh\u00e0 b\u1ec7nh h\u1ecdc, chuy\u00ean gia tin sinh h\u1ecdc, k\u1ef9 thu\u1eadt vi\u00ean x\u00e9t nghi\u1ec7m v\u00e0 c\u00e1c chuy\u00ean gia ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe kh\u00e1c gi\u1ea3i th\u00edch th\u00eam. Th\u00f4ng tin t\u1eeb MTBs (Molecular tumour board, ca\u0301c H\u1ed9i \u0111\u1ed3ng chuy\u00ean v\u00ea\u0300 kh\u1ed1i u c\u00e2\u0301p \u0111\u00f4\u0323 ph\u00e2n t\u1eed) \u0111\u01b0\u1ee3c chia s\u1ebb th\u00f4ng qua c\u00e1c b\u00e1o c\u00e1o c\u00f3 th\u1ec3 t\u1ea3i xu\u1ed1ng \u0111i\u1ec7n t\u1eed t\u1eeb h\u1ed3 s\u01a1 b\u1ec7nh \u00e1n ho\u1eb7c h\u1ec7 th\u1ed1ng c\u1ee7a b\u1ec7nh vi\u1ec7n. M\u1ed9t nh\u00f3m tin sinh h\u1ecdc n\u1ed9i b\u1ed9 th\u01b0\u1eddng xuy\u00ean c\u1eadp nh\u1eadt c\u01a1 s\u1edf d\u1eef li\u1ec7u \u0111\u1ec3 c\u00f3 th\u1ec3 b\u1ed5 sung khuy\u1ebfn ngh\u1ecb \u0111i\u1ec1u tr\u1ecb v\u00e0 th\u00f4ng tin thu\u1ed1c v\u00e0o b\u00e1o c\u00e1o NGS (next-generation sequencing, c\u00f4ng ngh\u1ec7 gi\u1ea3i tr\u00ecnh t\u1ef1 th\u1ebf h\u1ec7 m\u1edbi).<\/p>

L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 b\u0103\u0301t \u0111\u00e2\u0300u \u0111\u01b0\u01a1\u0323c m\u1ed9t MTB (Molecular tumour board, H\u1ed9i \u0111\u1ed3ng chuy\u00ean v\u00ea\u0300 kh\u1ed1i u c\u00e2\u0301p \u0111\u00f4\u0323 ph\u00e2n t\u1eed)<\/h3>

M\u1eb7c d\u00f9 MTBs (Molecular tumour boards, ca\u0301c H\u1ed9i \u0111\u1ed3ng chuy\u00ean v\u00ea\u0300 kh\u1ed1i u c\u00e2\u0301p \u0111\u00f4\u0323 ph\u00e2n t\u1eed) c\u00f3 v\u1ebb \u0111\u00e1ng s\u1ee3 khi b\u1eaft \u0111\u1ea7u, nh\u01b0ng ngay c\u1ea3 nh\u1eefng b\u01b0\u1edbc nh\u1ecf c\u0169ng c\u00f3 th\u1ec3 t\u1ea1o n\u00ean s\u1ef1 kh\u00e1c bi\u1ec7t. M\u1ed9t b\u01b0\u1edbc quan tr\u1ecdng l\u00e0 \u0111\u00e0o t\u1ea1o c\u00e1c \u0111\u1ed1i t\u00e1c l\u00e2m s\u00e0ng v\u1ec1 gi\u00e1 tr\u1ecb c\u1ee7a d\u1eef li\u1ec7u NGS (next-generation sequencing, c\u00f4ng ngh\u1ec7 gi\u1ea3i tr\u00ecnh t\u1ef1 th\u1ebf h\u1ec7 m\u1edbi) trong vi\u1ec7c h\u01b0\u1edbng d\u1eabn ch\u1ea9n \u0111o\u00e1n v\u00e0 \u0111i\u1ec1u tr\u1ecb ung th\u01b0 cho b\u1ec7nh nh\u00e2n, v\u00e0 \u0111i\u1ec1u n\u00e0y c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c th\u1ef1c hi\u1ec7n b\u1eb1ng c\u00e1ch chia s\u1ebb m\u1ed9t v\u00e0i b\u00e0i b\u00e1o khoa h\u1ecdc ho\u1eb7c nghi\u00ean c\u1ee9u tr\u01b0\u1eddng h\u1ee3p l\u00e2m s\u00e0ng c\u00f3 li\u00ean quan.<\/p>

Vi\u1ec7c h\u1ee3p t\u00e1c v\u1edbi c\u00e1c khoa kh\u00e1c \u2014 ho\u1eb7c th\u1eadm ch\u00ed c\u00e1c h\u1ec7 th\u1ed1ng y t\u1ebf kh\u00e1c \u2014 c\u0169ng c\u00f3 th\u1ec3 gi\u00fap t\u1eadp h\u1ee3p chuy\u00ean m\u00f4n c\u1ea7n thi\u1ebft cho m\u1ed9t cu\u1ed9c th\u1ea3o lu\u1eadn MTB (Molecular tumour board, H\u1ed9i \u0111\u1ed3ng chuy\u00ean v\u00ea\u0300 kh\u1ed1i u c\u00e2\u0301p \u0111\u00f4\u0323 ph\u00e2n t\u1eed) h\u1eefu \u00edch. T\u1ea5t nhi\u00ean, ch\u1ec9 c\u1ea7n th\u00eam m\u1ed9t nh\u00e0 b\u1ec7nh h\u1ecdc ph\u00e2n t\u1eed v\u00e0o c\u00e1c h\u1ed9i \u0111\u1ed3ng kh\u1ed1i u hi\u1ec7n c\u00f3 c\u0169ng \u0111\u1ee7 \u0111\u1ec3 kh\u01a1i m\u00e0o cu\u1ed9c th\u1ea3o lu\u1eadn v\u1ec1 t\u00ednh h\u1eefu \u00edch c\u1ee7a vi\u1ec7c k\u1ebft h\u1ee3p d\u1eef li\u1ec7u NGS (next-generation sequencing, c\u00f4ng ngh\u1ec7 gi\u1ea3i tr\u00ecnh t\u1ef1 th\u1ebf h\u1ec7 m\u1edbi) cho c\u00e1c tr\u01b0\u1eddng h\u1ee3p ung th\u01b0.<\/p>

\u0110\u1ec3 bi\u1ebft th\u00eam th\u00f4ng tin v\u1ec1 c\u00e1ch ti\u1ebfn h\u00e0nh MTB (Molecular tumour board, H\u1ed9i \u0111\u1ed3ng chuy\u00ean v\u00ea\u0300 kh\u1ed1i u c\u00e2\u0301p \u0111\u00f4\u0323 ph\u00e2n t\u1eed) c\u1ee7a ri\u00eang b\u1ea1n, h\u00e3y xem qua nh\u1eefng<\/em>ngu\u1ed3n t\u00e0i li\u1ec7u tuy\u1ec7t v\u1eddi n\u00e0y:B\u00e0i \u0111\u00e1nh gi\u00e1 h\u1eefu \u00edch<\/p>